Clinical Trial Update: Chiglitazar Added to Metformin for Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding chiglitazar to metformin for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)
• metformin (metformin)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED